Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for biomarker testing that is supported by medical and scientific evidence; establishing requirements for deductibles, copayments, and coinsurance for biomarker testing; and requiring the Maryland Health Care Commission to report to certain committees of the General Assembly on the impact of providing biomarker testing.